Immunic Inc (IMUX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $102.61M
Last updated: Nov 17, 2026 at 11:05 AM ET
Immunic Inc (IMUX) Competitors
The companies most similar to Immunic are ImmuCell (ICCC), Equillium (EQ) and INmune Bio (INMB). By market cap, Immunic ranks 5th of the 13 companies on this page; NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is the largest at $141.66M.
Peer Comparison
IMUX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Immunic (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| ImmuCell Corporation (ICCC) | $97.73M | 57.2x | 3.1x | 2.6% | 4.6% | 11.5% | 0.00% |
| Equillium Inc (EQ) | $106.20M | N/A | 29.3x | 0.0% | N/A | -52.3% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Anixa Biosciences Inc (ANIX) | $91.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Coherus BioSciences Inc (CHRS) | $81.21M | N/A | 1.5x | -253.4% | -144.8% | 23.4% | 0.00% |
| Unicycive Therapeutics Inc (UNCY) | $97.25M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Minerva Neurosciences Inc (NERV) | $114.62M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| MacroGenics Inc (MGNX) | $140.60M | N/A | 1.2x | -36.6% | -108.7% | -64.8% | 0.00% |
| Peer median | $94.16M | 57.2x | 16.2x | 0.0% | -126.7% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Immunic, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| ImmuCell Corporation (ICCC) | ImmuCell Corporation, an animal health company, develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle... | ICCC competitors |
| Equillium Inc (EQ) | Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory... | EQ competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Anixa Biosciences Inc (ANIX) | Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. | ANIX competitors |
| Coherus BioSciences Inc (CHRS) | Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. | CHRS competitors |
| Unicycive Therapeutics Inc (UNCY) | Unicycive Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering therapies for kidney diseases... | UNCY competitors |
| Minerva Neurosciences Inc (NERV) | Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products... | NERV competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| MacroGenics Inc (MGNX) | MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. | MGNX competitors |
Frequently Asked Questions About IMUX
Who are Immunic's main competitors?
The companies most similar to Immunic include ImmuCell (ICCC), Equillium (EQ), INmune Bio (INMB), Mink Therapeutics (INKT) and ImageneBio (IMA), listed from the closest match.
Who is Immunic's biggest competitor?
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is the largest of the similar companies at $141.66M; ImmuCell (ICCC) is the closest match by business profile, size, sector and industry.
How does IMUX stock compare with its competitors?
IMUX's net margin is 0.0% against a peer median of 0.0%.
Which of Immunic's competitors pays a higher dividend?
Immunic pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Immunic bigger than its competitors?
No. Immunic is 5th by market cap among the 13 companies on this page; the largest is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) at $141.66M.
IMUX pages: Overview, Earnings, Forecast, Financials, Competitors